Download Files:
MSX-122
SKU
HY-13696-10 mg
Category Reference compound
Tags Cancer; Inflammation/Immunology; Endocrinology, CXCR, GPCR/G Protein;Immunology/Inflammation
$92 – $726
Products Details
Product Description
– MSX-122 is an orally active partial antagonist of CXCR4, inhibiting CXCR4/CXCL12 actions, with an IC50 of ∼10 nM. MSX-122 has anti-inflammatory and anti-metastatic activity.
Web ID
– HY-13696
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C16H16N6
References
– [1]Liang Z, et al. Development of a unique small molecule modulator of CXCR4. PLoS One. 2012;7(4):e34038.
CAS Number
– 897657-95-3
Molecular Weight
– 292.34
Compound Purity
– 98.92
SMILES
– C1(CNC2=NC=CC=N2)=CC=C(CNC3=NC=CC=N3)C=C1
Clinical Information
– Phase 1
Research Area
– Cancer; Inflammation/Immunology; Endocrinology
Solubility
– DMSO : 4 mg/mL (ultrasonic)
Target
– CXCR
Isoform
– CXCR4
Pathway
– GPCR/G Protein;Immunology/Inflammation
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.